This review summarizes the current understanding of spinal cord injury pathophysiology and
discusses important emerging regenerative approaches that have been translated into …

Traumatic spinal cord injuries (SCIs) affect 1.3 million North Americans, producing
devastating physical, social, and vocational impairment. Pathophysiologically, the initial …

Since several years, adult/perinatal mesenchymal and neural crest stem cells have been
widely used to help experimental animal to recover from spinal cord injury. More …

Spinal cord injury (SCI) often results in significant dysfunction and disability. A series of
treatments have been proposed to prevent and overcome the formation of the glial scar and …

Recent advances in stem cell biology present significant opportunities to advance clinical
applications of stem cell–based therapies for spinal cord injury (SCI). In this review, the …

Spinal cord injury is a severely disabling neurological condition leading to impaired mobility,
pain, and autonomic dysfunction. Most often, a single traumatic event, such as a traffic or …

Spinal cord injury (SCI) research is a very complex field lending to why reviews of SCI
literatures can be beneficial to current and future researchers. This review focuses on recent …

Acute spinal cord injury (SCI) is a devastating neurological disorder that can affect any
individual at a given instance. Current treatment options for SCI include the use of high dose …

More than 1 million people in the United States live with a spinal cord injury (SCI). Despite
medical advances, many patients with SCIs still experience substantial neurological …

✓ Despite advances in medical and surgical care, the current clinical therapies for spinal
cord injury (SCI) are largely ineffective. During the last 2 decades, the search for new …